Targeting mahogany

The most straightforward mechanism for a small molecule therapeutic agent is to inactivate the product of a single gene. However for diseases with a complex genetic basis it may be difficult to identify a single "slam dunk" target. Thus the identification and cloning of the mahogany gene by researchers at Millennium Pharmaceuticals Inc.

Read the full 532 word article

How to gain access

Continue reading with a
two-week free trial.